Junshik Hong

3.0k total citations
179 papers, 2.0k citations indexed

About

Junshik Hong is a scholar working on Hematology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Junshik Hong has authored 179 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Hematology, 74 papers in Oncology and 43 papers in Pathology and Forensic Medicine. Recurrent topics in Junshik Hong's work include Acute Myeloid Leukemia Research (44 papers), Lymphoma Diagnosis and Treatment (37 papers) and Hematopoietic Stem Cell Transplantation (20 papers). Junshik Hong is often cited by papers focused on Acute Myeloid Leukemia Research (44 papers), Lymphoma Diagnosis and Treatment (37 papers) and Hematopoietic Stem Cell Transplantation (20 papers). Junshik Hong collaborates with scholars based in South Korea, United States and Puerto Rico. Junshik Hong's co-authors include Jinny Park, Dong Bok Shin, Eun Kyung Cho, Sun Jin Sym, Jae Hoon Lee, Dong‐Yeop Shin, Mi Sun Park, Young Saing Kim, Ju‐Young Jung and Dongbum Suh and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Junshik Hong

164 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junshik Hong South Korea 25 685 498 466 354 325 179 2.0k
Hassan Izzedine France 27 530 0.8× 738 1.5× 271 0.6× 168 0.5× 410 1.3× 94 2.1k
Vinod Raina India 20 645 0.9× 348 0.7× 286 0.6× 193 0.5× 324 1.0× 102 1.6k
Clarence Lam China 19 364 0.5× 346 0.7× 288 0.6× 245 0.7× 207 0.6× 42 1.4k
Michael G. Alexandrakis Greece 29 767 1.1× 498 1.0× 223 0.5× 755 2.1× 573 1.8× 104 2.3k
Daniela Cabibi Italy 35 330 0.5× 252 0.5× 731 1.6× 81 0.2× 523 1.6× 160 4.2k
Frank S. Fan Taiwan 20 358 0.5× 224 0.4× 198 0.4× 217 0.6× 256 0.8× 84 1.4k
Hanny Al‐Samkari United States 31 461 0.7× 579 1.2× 203 0.4× 1.6k 4.5× 275 0.8× 193 3.8k
Roberto Dall’Amico Italy 22 233 0.3× 259 0.5× 107 0.2× 658 1.9× 156 0.5× 62 2.0k
Prue Hill Australia 21 332 0.5× 257 0.5× 295 0.6× 62 0.2× 333 1.0× 57 1.8k
F. Berthoux France 32 245 0.4× 529 1.1× 492 1.1× 547 1.5× 287 0.9× 143 3.7k

Countries citing papers authored by Junshik Hong

Since Specialization
Citations

This map shows the geographic impact of Junshik Hong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junshik Hong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junshik Hong more than expected).

Fields of papers citing papers by Junshik Hong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junshik Hong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junshik Hong. The network helps show where Junshik Hong may publish in the future.

Co-authorship network of co-authors of Junshik Hong

This figure shows the co-authorship network connecting the top 25 collaborators of Junshik Hong. A scholar is included among the top collaborators of Junshik Hong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junshik Hong. Junshik Hong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lee, Hyukmin, Moon‐Woo Seong, Ja Min Byun, et al.. (2025). Prognostic Landscape of <i>TP53</i> Mutations in Hematologic Malignancies. Cancer Research and Treatment.
2.
Kong, Jee Hyun, Junshik Hong, Ja Min Byun, et al.. (2025). Azacitidine followed by R-GDP in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma: preliminary results from a multicenter, phase II study. Therapeutic Advances in Hematology. 16. 1584267121–1584267121. 2 indexed citations
3.
Mascarenhas, John, Raajit K. Rampal, Prithviraj Bose, et al.. (2024). Phase 3 randomized double-blind study evaluating selinexor, an XPO1 inhibitor, plus ruxolitinib in JAKi-naïve myelofibrosis.. Journal of Clinical Oncology. 42(16_suppl). TPS6594–TPS6594. 1 indexed citations
4.
Koh, Young‐Il, Ja Min Byun, Junshik Hong, et al.. (2024). Glofitamab combined with poseltinib and lenalidomide for relapsed/refractory diffuse large B cell lymphoma: Interim analysis of GPL study.. Journal of Clinical Oncology. 42(16_suppl). 7066–7066. 2 indexed citations
5.
Kim, Seokhyeon, Ja Min Byun, Junshik Hong, et al.. (2024). Phase II trial of imatinib mesylate in patients with PDGFRA/B ‐negative hypereosinophilic syndrome. British Journal of Haematology. 205(6). 2305–2314. 2 indexed citations
6.
Lee, Sung‐Eun, Junshik Hong, Soo‐Mee Bang, et al.. (2024). Differences in Clinical Outcomes Between Hydroxyurea-Resistant and -Intolerant Polycythemia Vera Patients. Journal of Korean Medical Science. 39(3). e24–e24.
7.
Hwang, Hun-Gyu, Ju Hyun Lee, Yang‐Ki Kim, et al.. (2024). Direct Oral Anticoagulants in Antiphospholipid Syndrome-Associated Venous Thromboembolism: Real World Evidence. Journal of Korean Medical Science. 39(36). e252–e252. 1 indexed citations
8.
Kim, Sheehyun, Ja Min Byun, Youngil Koh, et al.. (2024). Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy. Cancer Medicine. 13(7). e7182–e7182. 1 indexed citations
9.
Park, Mi-Young, Dongho Kim, Ja Min Byun, et al.. (2024). Genetic Risk Factors for Bortezomib-induced Neuropathic Pain in an Asian Population: A Genome-wide Association Study in South Korea. Journal of Pain. 25(9). 104552–104552.
10.
Youk, Jeonghwan, Ja Min Byun, Youngil Koh, et al.. (2023). Effects of tertiary palliative care on the pattern of end‐of‐life care in patients with hematologic malignancies in Korea. European Journal Of Haematology. 112(5). 743–755. 6 indexed citations
11.
Liu, Jun, Dong Chan Kim, Jihyun Park, et al.. (2023). Pharmacological GLUT3 salvage augments the efficacy of vitamin C-induced TET2 restoration in acute myeloid leukemia. Leukemia. 37(8). 1638–1648. 4 indexed citations
12.
Hong, Junshik, et al.. (2023). Understanding and treatment of cutaneous graft-versus-host-disease. Bone Marrow Transplantation. 58(12). 1298–1313. 5 indexed citations
13.
Ahn, Hyun Jin, Ja Min Byun, Inho Kim, et al.. (2022). Eltrombopag for Post-Transplant Poor Graft Function in East Asian Patients. Journal of Korean Medical Science. 37(6). e48–e48. 3 indexed citations
14.
Jung, Eun Hee, Junshik Hong, Sung‐Yong Kim, et al.. (2022). Real-World Outcomes of Ruxolitinib in Patients With Myelofibrosis Focusing on Red Blood Cell Transfusion: A Multicenter Study From the MPN Working Party of the Korean Society of Hematology. Clinical Lymphoma Myeloma & Leukemia. 22(10). e931–e937. 1 indexed citations
15.
Lee, Yeji, Inho Kim, Dong‐Yeop Shin, et al.. (2022). The immediate impact of physical function and quality of life after hematopoietic stem cell transplantation. Supportive Care in Cancer. 30(9). 7439–7446. 1 indexed citations
16.
Hwang, Hun-Gyu, Ju Hyun Lee, Yang‐Ki Kim, et al.. (2022). Incidence of Venous Thromboembolism: The 3rdKorean Nationwide Study. Journal of Korean Medical Science. 37(17). e130–e130. 10 indexed citations
17.
18.
Lee, Soon‐Tae, Ja Min Byun, Junshik Hong, et al.. (2020). High Cell-Free DNA Levels in Cerebrospinal Fluid Predict Leptomeningeal Seeding of Hematologic Malignancy. Journal of Clinical Neurology. 16(4). 581–581. 3 indexed citations
19.
Hong, Junshik, Ju Hyun Lee, Ja Min Byun, et al.. (2019). Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms. Blood Advances. 3(22). 3700–3708. 22 indexed citations
20.
Hong, Junshik, Soo‐Mee Bang, Yeung‐Chul Mun, et al.. (2018). Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP). Journal of Korean Medical Science. 33(19). e142–e142. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hassan Izzedine Breakdown of academic impact, for papers by Vinod Raina Breakdown of academic impact, for papers by Clarence Lam Breakdown of academic impact, for papers by Michael G. Alexandrakis Breakdown of academic impact, for papers by Daniela Cabibi Breakdown of academic impact, for papers by Frank S. Fan Breakdown of academic impact, for papers by Hanny Al‐Samkari Breakdown of academic impact, for papers by Roberto Dall’Amico Breakdown of academic impact, for papers by Prue Hill Breakdown of academic impact, for papers by F. Berthoux
Rankless by CCL
2026